Analysis of Immunohistochemical Expression of K19 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma Using Color Deconvolution-Image Analysis Method

Head and Neck Pathology

Volumn 4, Issue 4, 2010, Pages 282-289

  Safadi, Rima A ^a,b   Musleh, Atika S ^c   Al Khateeb, Taiseer H ^a,b   Hamasha, Abed Al Hadi ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

^c Ministry of Health   (Jordan)

Author keywords

Epithelial dysplasia; Image analysis; Immunohistochemistry; K19; Oral squamous cell carcinoma

Indexed keywords

CYTOKERATIN 19; EOSIN; HEMATOXYLIN; PARAFFIN; TUMOR MARKER;

ARTICLE; BIOPSY; CELL DIFFERENTIATION; EPITHELIUM CELL; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; STAINING;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; EOSINE YELLOWISH-(YS); EPITHELIAL CELLS; HEMATOXYLIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KERATIN-19; MOUTH NEOPLASMS; PARAFFIN EMBEDDING; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 78650054407     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-010-0210-6     Document Type: Article

References (28)

1. De Vicente J, Recio O, Pendás S, et al. Oral squamous cell carcinoma of the mandibular region A survival study. Head Neck. 2001; 23(7): 536-43.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009; 45(4-5): 309-16.
3. Silverman SJ, Sugerman P. Oral premalignancies and squamous cell carcinoma. Clin Dermatol. 2000; 18(5): 563-8.
4. Kramer I, Lucas R, Pindborg J, et al. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978; 46(4): 518-39.
5. Silverman SJ, Gorsky M, Kaugars G. Leukoplakia, dysplasia, and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82(2): 117.
6. Abbey L, Kaugars G, Gunsolley J, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Pathol Oral Radiol Endod. 1995; 80(2): 188-91.
7. Brothwell DJ, Lewis DW, Bradley G, et al. Observer agreement in the grading of oral epithelial dysplasia. Community Dent Oral Epidemiol. 2003; 31(4): 300-5.
8. Fischer DJ, Epstein JB, Morton TH, et al. Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. J Oral Pathol Med. 2004; 33(2): 65-70.
9. Hu L, Crowe DL, Rheinwald JG, et al. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991; 51(15): 3972-81.
10. Takeda T, Sugihara K, Hirayama Y, et al. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med. 2006; 35(6): 369-75.
11. Warnakulasuriya S. Lack of molecular markers to predict malignant potential of oral precancer. J Pathol. 2000; 190(4): 407-9.
12. Fradette J, Germain L, Seshaiah P, et al. The type I keratin 19 possesses distinct and context-dependent assembly properties. J Biol Chem. 1998; 273(52): 35176-84.
13. Michel M, Torok N, Godbout MJ, et al. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: Keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci. 1996; 109(Pt5): 1017-70.
14. Lindberg K, Rheinwald JG. Suprabasal 40kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol. 1989; 134(1): 89-98.
15. Zhong LP, Chen WT, Zhang CP, et al. Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 104(3): 377-84.
16. Anneroth G, Hansen LS. A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res. 1984; 92(5): 448-68.
17. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001; 23(4): 291-9.
18. Elias JM, Gown AM, Nakamura RM, et al. Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. Am J Clin Pathol. 1989; 92(6): 836-43.
19. Fillies T, Jogschies M, Kleinheinz J, et al. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep. 2007; 18(3): 639-43.
20. Nie M, Zhong L, Zeng G, et al. The changes of cytokeratin 19 during oral carcinogenesis. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002; 37(3): 187-90.
21. Küffer R, Lombardi T. Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN). Oral Oncol. 2002; 38(2): 125-30.
22. Warnakulasuriya S, Reibel J, Bouquot J, et al. Oral epithelial dysplasia classification systems: Predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008; 37(3): 127-33.
23. Kujan O, Oliver RJ, Khattab A, et al. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006; 42(10): 987-93.
24. Su L, Morgan PR, Thomas JA, et al. Expression of keratin 14 and 19 mRNA and protein in normal oral epithelia, hairy leukoplakia, tongue biting and white sponge nevus. J Oral Pathol Med. 1993; 22(4): 183-9.
25. Toyoshima T, Vairaktaris E, Nkenke E, et al. Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. J Cancer Res Clin Oncol Erratum in: J Cancer Res Clin Oncol. 2008; 34(4): 523-24, 134(4): 515-21.
26. Fillies T, Werkmeister R, Packeisen J, et al. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer. 2006; 13(6): 10.
27. Yoshida Y. [Effective biological marker to detect oral squamous cancer cells-expression patterns of CK 10, 17, 19 and SCCA mRNA-]. Kokubyo, Gakkai Zasshi. 2007; 73 74 (3, 1): 37-42.
28. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis. 1998; 4(2): 70-7.